# DESCRIPTION

## STATEMENT OF GOVERNMENT INTEREST

- disclose government support

## BACKGROUND OF THE INVENTION

- motivate apoptosis regulation
- summarize BCL-2 protein family function
- describe BAX activation pathway

## SUMMARY OF THE INVENTION

- disclose Fab antibodies for BAX inhibition

## DETAILED DESCRIPTION OF THE INVENTION

- introduce synthetic Fab antibody
- describe Fab antibody structure
- list different embodiments of Fab
- describe Fab binding to BAX
- describe Fab production methods
- describe method of inhibiting apoptotic cell death
- describe method of measuring inactive monomeric BAX levels
- describe method for screening small molecules
- describe method of predicting cancer therapy effectiveness
- provide definitions and scope of invention

### Introduction

- introduce synthetic antibody technology
- describe rationale for using in vitro selection

### Materials and Methods

- produce recombinant BAX
- express Fab proteins
- purify Fab proteins
- describe origin of CDR regions
- convert antibodies to scFvs
- clone and express scFvs in cells
- perform direct binding ELISAs
- perform competitive binding ELISAs
- analyze binding kinetics using biolayer interferometry
- perform size-exclusion chromatography
- conduct liposome permeabilization assay
- perform BAX translocation assay
- perform mitochondrial release assay
- perform Western blotting
- perform NMR spectroscopy and hydrogen/deuterium exchange mass spectrometry

### Results

- describe phage antigen-binding fragment (Fab) library design
- introduce Library F and its characteristics
- describe screening of Library F against monomeric BAX
- summarize selection of 14 BAX-specific Fabs with diverse CDR sequences
- describe expression and purification of Fabs
- determine half-maximal binding titers (EC50) for BAX using ELISA
- evaluate binding kinetics to monomeric BAX using Biolayer Interferometry
- perform competitive ELISA to explore epitopes on BAX
- describe liposomal assays to examine Fab modulation of BAX function
- analyze Fab inhibition of BH3-triggered BAX activation and MOMP
- examine Fab 3G11 protein binding to BAX using size-exclusion chromatography
- analyze Fab 3G11-BAX complex formation using NMR titration
- describe hydrogen-deuterium exchange mass spectrometry (HXMS) analysis of Fab-BAX interaction

### DISCUSSION

- discuss importance of BAX in mitochondrial apoptotic pathway
- summarize generation of high-affinity BAX-binding antibody fragments (Fabs)
- describe mechanism of Fab inhibition of BAX activation
- discuss potential therapeutic applications of Fabs as probes for small molecule discovery

